![[del.icio.us]](http://pennystockdd.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://pennystockdd.com/wp-content/plugins/bookmarkify/digg.png)
![[Faves]](http://pennystockdd.com/wp-content/plugins/bookmarkify/faves.png)
![[LinkedIn]](http://pennystockdd.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://pennystockdd.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://pennystockdd.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Technorati]](http://pennystockdd.com/wp-content/plugins/bookmarkify/technorati.png)
Today’s top day trader and active trader alerts are in ANF, AKNS, ABK, AIG, CTIC, IS, HD, NFLX, SPRD, and WMT.
Regards,
Don
Tag: ctic
Stocks to Watch – 5/10/10 – Stock Market Investing Ideas
Pacific Capital Bancorp (PCBC) – Shares of Pacific Capital Bancorp were up for a 4th straight day on Friday and continue to be the only bright spot in this stock market. Keep it high on your watchlist but this is a trading stock only. Recent Positive News
Power-One Inc. (PWER) – Shares of Power-One Inc. continue to offer awesome trading opportunities. If we get another stock market plunge, I’d be a buyer below $6.50 for bounce trade.
Keryx Biopharmaceuticals Inc. (KERX) – Shares of Keryx Biopharmaceuticals Inc. finally got killed like everything else in the stock market. Resistance continues to be located at $6.10 going forward.
(Read the Rest of the Article…)
Regards,
Don
More on this topic
(What's this?)
Power One (PWER) Vaults Another 20% After Earnings, Posts Record Revs
(Green Stocks Central, 4/29/10)
Power-One (PWER) Breaks Out On Patent Licensing Deal, Dismissal Of Lawsuits
(Green Stocks Central, 4/15/10)
Power-One is Riding High
(Momentum Stocks, 5/3/10)
Power-One ($PWER) Added to VSG Watch List
(Value Stock Guide, 4/9/12)
Cell Therapeutics (CTIC: 0.66 +0.0213 +3.33%)) – The stock continued to move downward to sideways.
Ambac Financial Group (ABK: 1.94 +0.18 +10.23%) – The stock had a very large spread last Monday, which was accompanied with large volume as well. It is possible that this stock may be forming a flag or pennant formation
(Read the Rest of the Article…)
Regards,
Don
More on this topic
(What's this?)
Equal Weight and Fundamental Indexing Beats The Market
(Value Investing, 5/16/12)
Sunpeaks Ventures SNPK.OB: The Facts, Figures and Faux Pas
(Morningpick, 4/5/12)
New Invisibility Technology Keeps Waves From Rocking the Boat
(Wall Street Daily, 3/8/12)
Google [X] Group Project Glass: One day
(Value Investing, 4/11/12)
Here is some excellent material for Investors who like Biotechs as much as I do.
Generex Biotechnology Corporation (NASDAQ:GNBT) has the 1st highest upside potential in this segment of the market. Its upside is 973.3%. Its consensus target price is $6.00 based on the average of all estimates. Cell Therapeutics, Inc. (NASDAQ:CTIC) has the 2nd highest upside potential in this segment of the market. Its upside is 696.0%. Its consensus target price is $3.74 based on the average of all estimates. ARYx Therapeutics, Inc. (NASDAQ:ARYX) has the 3rd highest upside potential in this segment of the market. Its upside is 641.8%. Its consensus target price is $6.75 based on the average of all estimates. Encorium Group Inc. (NASDAQ:ENCO) has the 4th highest upside potential in this segment of the market. Its upside is 346.4%. Its consensus target price is $6.47 based on the average of all estimates. YM BioSciences Inc. (USA) (AMEX:YMI) has the 5th highest upside potential in this segment of the market. Its upside is 325.3%. Its consensus target price is $4.99 based on the average of all estimates.
Opexa Therapeutics Inc. (NASDAQ:OPXA) has the 6th highest upside potential in this segment of the market. Its upside is 314.5%. Its consensus target price is $8.00 based on the average of all estimates. Nile Therapeutics, Inc. (NASDAQ:NLTX) has the 7th highest upside potential in this segment of the market. Its upside is 257.1%. Its consensus target price is $4.00 based on the average of all estimates. Inovio Biomedical Corp. (AMEX:INO) has the 8th highest upside potential in this segment of the market. Its upside is 233.3%. Its consensus target price is $4.00 based on the average of all estimates. DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA) has the 9th highest upside potential in this segment of the market. Its upside is 212.5%. Its consensus target price is $6.00 based on the average of all estimates. Bionovo Inc. (NASDAQ:BNVI) has the 10th highest upside potential in this segment of the market. Its upside is 205.4%. Its consensus target price is $1.50 based on the average of all estimates.
DRD PICKS
(Read the Rest of the Article…)
Regards,
Don
VVUS --- TOP ALERT FROM LAST WEEK VVUS --- NEWS ALERT VVUS --- March 8 /PRNewswire-FirstCall/ -- VIVUS, Inc.today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. (Read the Rest of the Article...)
Regards,
Don
More on this topic
(What's this?)
Options Trade for FDA Panel Decision – VVUS
(, 7/1/10)
Weight Loss Stocks: ARNA, VVUS, and OREX Race to End the Obesity Epidemic
(Money Morning, 4/10/12)
VVUS
(All Allan, 5/6/10)
(VVUS) VIVUS Obesity Drug Application for Qnexa to Get FDA Review
(Stock Blog Hub, 3/29/10)
Some interesting stocks popped up on our Wednesday watch list scans, you may recognize a few of them right off the bat.
The small cap ETF, PWT which is the chart on the right, shows a familiar patter like we have seen for the broader markets. A move over $12 would be a good technical break out from this range. Keep an eye on such charts as a bell weather for the mood of investors in small caps.
(Read the Rest of the Article…)
Regards,
Don
